PSMA Response in Metastasized Hormone Sensitive Prostate Cancer
NCT05161728 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2024-01-09
Summary
PSMA-PET/CT response measurements after LHRH agonist and upfront therapy in men diagnosed with de novo metastasized hormonal sensitive prostate cancer.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
PSMA-PET/CT
PSMA-PET/CT
Sponsors & Collaborators
-
Roderick van den Bergh
lead OTHER
Principal Investigators
-
Marnix Lam, MD PhD · UMC Utrecht
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-19
- Primary Completion
- 2025-10-19
- Completion
- 2025-10-19
Countries
- Netherlands
Study Locations
More Related Trials
-
PSMA-PET/CT Registry
NCT05709535 ·Status: TERMINATED
-
18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
NCT04487847 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
NCT04298112 ·Status: COMPLETED
-
PSMA-PET/CT for Prostate Cancer
NCT03558711 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer
NCT05712174 ·Status: TERMINATED ·Phase: PHASE2
-
PSMA-Guided Ablation of the Prostate
NCT06003556 ·Status: RECRUITING ·Phase: PHASE2
-
PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility
NCT03486886 ·Status: COMPLETED ·Phase: NA
-
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
NCT02825875 ·Status: COMPLETED
-
Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate Cancer
NCT03938766 ·Status: COMPLETED ·Phase: NA
-
Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06462495 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Effect of ADT on PSMA-PET.
NCT03313726 ·Status: UNKNOWN ·Phase: NA
-
High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer
NCT03327675 ·Status: RECRUITING ·Phase: NA
-
Novel Imaging in Staging of Primary Prostate Cancer
NCT03537391 ·Status: COMPLETED ·Phase: NA
-
18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer
NCT04733768 ·Status: COMPLETED ·Phase: PHASE2
-
PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer
NCT03594760 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Diagnostic Performance of [18F]CTT1057 in BCR
NCT04838613 ·Status: COMPLETED ·Phase: PHASE3
-
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
NCT03768349 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy
NCT04053842 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
NCT04557501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis
NCT06756334 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies
NCT07258056 ·Status: RECRUITING ·Phase: NA
-
Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
NCT06335914 ·Status: RECRUITING ·Phase: NA
-
PSMA PET/CT for Prostate Cancer
NCT03573011 ·Status: COMPLETED ·Phase: PHASE2
-
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
NCT05761366 ·Status: RECRUITING ·Phase: PHASE2
-
Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model
NCT05587192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA